Azithromycin vs Roflumilast for AECOPD
A UCLA Health study compared azithromycin and roflumilast in protecting against acute exacerbations of chronic obstructive pulmonary disease (AECOPD).
A UCLA Health study compared azithromycin and roflumilast in protecting against acute exacerbations of chronic obstructive pulmonary disease (AECOPD).
Men receiving systemic testosterone therapy showed a statistically significant decrease in inhaled corticosteroid use starting 18 to 24 months after treatment initiation.
Windward Bio is evaluating WIN378, a monoclonal antibody designed for twice-yearly dosing in patients with moderate-to-severe COPD.
A collaboration between Jiva.ai and Aevice Health has developed a predictive model that identifies potential asthma exacerbations up to 72 hours in advance.
American Lung Association is launching a new initiative to help the more than 16 million people in the US living with COPD manage symptoms and improve quality of life.
New data shows that patient visits and lung function tests for cystic fibrosis have not returned to 2019 levels despite new treatments and telehealth options.
Integrating genetic and telomere assessments into clinical care helps physicians refine diagnoses and adjust pulmonary fibrosis treatment plans.
New research suggests that microplastic particles can bind to allergens and carry them deeper into the respiratory system.
Martha Lillard, who was diagnosed with polio at age 5, passed away at the age of 78 after using an iron lung device for over seven decades.